To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
Clinical trial NCT05189548 · UNKNOWN
Trial details
- NCT number
- NCT05189548
- Sponsor
- Changchun BCHT Biotechnology Co.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2022-04-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.